LANXESS
Developer of Low Free (LF) isocyanate urethane prepolymers (Adiprene LF series) that enable formulation of high-performance, safe resins for 3D printing and additive manufacturing applications.
- CEO / Founder
- Matthias Zachert
- Team Size
- 10000+
- Stage
- Active
- Total Funding
- $4.0M
- Latest Round
- IPO
- Key Investors
- Lowell Capital Management; European Union
Technology & Products
Key Products
Adiprene LF pPDI (para-phenylene diisocyanate) prepolymers; Adiprene LF MDI (methylene diphenyl diisocyanate) prepolymers; Biobase Low Free isocyanate prepolymers; Polymer additives (flame retardants, plasticizers, colorants); Specialty lubricant additives
Technological Advantage
Proprietary Low Free isocyanate technology reduces free isocyanate to <0.1 wt% while maintaining reactivity and performance; defensible through ongoing R&D and production process know-how; enables safe, industrial-grade resin formulations unmatched by commodity suppliers.
Differentiation
Value Proposition
High-performance urethane prepolymers with <0.1% free isocyanate content deliver safety and ease of processing for industrial-grade and accessible 3D printing resin systems; enable rapid prototyping and on-demand manufacturing.
How They Differentiate
Low Free isocyanate prepolymers with <0.1% free isocyanate content; biobase formulations; safety-first approach enabling adoption across industrial, professional, and consumer 3D printing applications.
Market & Competition
Target Customers
3D printing resin manufacturers; industrial manufacturers; professional and consumer 3D printing users
Industry Verticals
3D printing / additive manufacturing; Adhesives and sealants; Paints and coatings; Lubricants; Plastics
Competitors
Arkema (specialty polymers and additives for 3D printing resins); BASF (polyurethane systems and 3D printing materials); Covestro (polyurethane raw materials)
Growth & Milestones
Growth Metrics
Revenue EUR 6.4 billion (2024), EUR 6.7 billion (2023); ~11,700-12,000 employees across 32 countries; EBITDA guidance EUR 600-650 million (2025, ~10% operational growth expected)
Major Milestones
Founded July 1, 2004 (spun off from Bayer); Acquisition of Chemtura (2016; expanded focus to additives for lubricants and flame retardants); Joint venture Arlanxeo with Saudi Aramco (2016; rubber business); Acquisition of Itibanyl (2020; Brazilian biocide manufacturer); Adiprene LF prepolymers launched for 3D printing (2019)
Notable Customers
3D printing resin manufacturers (names not disclosed); Vertico (architectural 3D printing); Industrial adhesive and sealant manufacturers